{"id":416164,"date":"2021-01-18T19:34:21","date_gmt":"2021-01-19T00:34:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=416164"},"modified":"2021-01-18T19:34:21","modified_gmt":"2021-01-19T00:34:21","slug":"canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/","title":{"rendered":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Canadian Pathology Quality Assurance will utilize the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diaceutics.com%2Fdxrx-network&amp;esheet=52362807&amp;newsitemid=20210118005033&amp;lan=en-US&amp;anchor=DXRX+platform%26%238217%3Bs+global+network&amp;index=1&amp;md5=5c5ae7b0cf23cdf07c25b5d2a7a844e7\">DXRX platform\u2019s global network<\/a> to support global implementation of their pan-TRK program <\/i><\/li>\n<li><i>Partnership will enable CPQA to produce best-in-class Neurotrophic Tropomyosin Receptor Kinase<\/i><i>IHC proficiency testing <\/i><\/li>\n<li><i>Laboratories can sign up to the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diaceutics.com%2Fdxrx-marketplace&amp;esheet=52362807&amp;newsitemid=20210118005033&amp;lan=en-US&amp;anchor=DXRX+marketplace&amp;index=2&amp;md5=a9fb6b70ce5b9162d87f72f97a216fa6\">DXRX marketplace<\/a> and avail of the opportunity to work with a world renowned External Quality Assessment provider <\/i><\/li>\n<li><i>DXRX is the world\u2019s first diagnostic network for precision medicine, enabling industry-wide collaboration to get every patient the treatment they deserve <\/i><\/li>\n<\/ul>\n<p>PARSIPPANY, New Jersey&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diaceutics.com%2F&amp;esheet=52362807&amp;newsitemid=20210118005033&amp;lan=en-US&amp;anchor=Diaceutics+PLC&amp;index=3&amp;md5=76a77b4b48d8343ebd215cd0d998597c\">Diaceutics PLC<\/a>, (AIM: DXRX), today announces a strategic partnership with Canadian Pathology Quality Assurance (CPQA) to advance the development of Neurotrophic Tropomyosin Receptor Kinase (NTRK) IHC proficiency testing globally.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20210118005033\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210118005033\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\" alt=\"Karina Hjort, Senior Director, Diaceutics (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">Karina Hjort, Senior Director, Diaceutics (Photo: Business Wire)<\/p>\n<\/div>\n<p>\nIn recent years, NTRK gene fusions have emerged as targets for cancer therapy due to advancing sequencing technologies. Globally, more labs are now testing for NTRK which means there is a growing demand for a robust Proficiency Testing (PT) program in this area.\n<\/p>\n<p>\nCPQA has identified the need to source Formalin-Fixed Paraffin-Embedded (FFPE) tissue blocks from laboratories to enable them to build a small tissue microarray for the purposes of NTRK IHC proficiency testing and the development of NTRK IHC validation assistance.\n<\/p>\n<p>\nThe organisation will utilize DXRX\u2019s vibrant marketplace to offer this unique collaboration opportunity to a global network of stakeholders in precision medicine diagnostics, including laboratories in close proximity to its facility \u2013 underscoring the pronounced value of DXRX-led networking.\n<\/p>\n<p>\nCPQA is dedicated to supporting the implementation of accurate and high-quality testing, with a particular focus on curating secretory breast carcinoma and\/or salivary Mammary Analogue Secretory Carcinoma (MASC) blocks, as these tissue types have a higher incidence of NTRK Fusions.\n<\/p>\n<p>\nAlong with having the chance to work with a renowned global External Quality Assessment (EQA) or Proficiency Testing (PT) providers, laboratories participating in the collaboration hosted on the DXRX platform will be eligible to participate in the CPQA pan-TRK EQA program free of charge.\n<\/p>\n<p><b>John Garratt, Director, CPQA said<i>:<\/i><\/b><i> \u201cWe are looking forward to taking advantage of Diaceutics\u2019 extensive network facilitated through DXRX. This will enable us to engage with labs globally in developing quality assurance material for biomarker testing to ensure accurate delivery of personalized therapeutics.\u201d<\/i><\/p>\n<p><b>Karina Hjort, Senior Director, Diaceutics said:<\/b><i> \u201cWe are delighted CPQA has been able to benefit from DXRX\u2019s targeted networking opportunities, enabling global precision medicine to unite around a common objective \u2013 greatly expediting what would generally be a very protracted lab recruitment process. <\/i><\/p>\n<p><i>\u201cA DXRX collaboration is an opportunity for multiple stakeholders to work together to solve real-world testing challenges at any stage of the diagnostic development and commercialization process, either by joining sponsored collaborations or creating their own on the marketplace. We look forward to partnering with CPQA and supporting future, similar programs on DXRX.\u201d<\/i><\/p>\n<p>\nThis collaboration on the platform\u2019s marketplace is live until March 26<sup>th<\/sup>, however registration may close once 20 labs have been enrolled.\n<\/p>\n<p><b>-Ends-<\/b><\/p>\n<p><b>About Diaceutics <\/b><\/p>\n<p>\nAt Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX &#8211; the world\u2019s first Network solution for the development and commercialization of precision medicine diagnostics. Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world\u2019s leading pharmaceutical companies. We have built the world\u2019s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.diaceutics.com&amp;esheet=52362807&amp;newsitemid=20210118005033&amp;lan=en-US&amp;anchor=www.diaceutics.com&amp;index=4&amp;md5=f8788f4eed7037bcba8c8d5e45e4ad2f\">www.diaceutics.com<\/a><\/p>\n<p><b>About CPQA-AQCP<\/b><\/p>\n<p>\nCPQA-AQCP partners with diagnostic medical laboratories to maintain a high standard of biomarker testing by providing samples that allow labs to test their performance.\n<\/p>\n<p>\nCPQA-AQCP is a not for profit organization that is one of the products of the evolution of a University of British Columbia programme originally founded in 2009, in response to the ever-changing landscape of diagnostic medical laboratory testing in Canadian and international laboratories. CPQA-AQCP continues to build on existing work to systematically monitor and improve the proficiency of medical laboratory testing across the country, facilitating participation by laboratories nationwide and internationally regardless of jurisdiction or existing accreditation requirements.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210118005033r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210118005033\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210118005033\/en\/<\/a><\/span><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/>Lorcan Byrne<br \/>\n<br \/>Comit Communications &amp; Marketing<br \/>\n<br \/>00353 1 2993000<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lorcan@comit.ie\">lorcan@comit.ie<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New Jersey United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Managed Care Research Pharmaceutical Science Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852607\/3\/DXRX_by_Diaceutics.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/3\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Karina Hjort, Senior Director, Diaceutics (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing Canadian Pathology Quality Assurance will utilize the DXRX platform\u2019s global network to support global implementation of their pan-TRK program Partnership will enable CPQA to produce best-in-class Neurotrophic Tropomyosin Receptor KinaseIHC proficiency testing Laboratories can sign up to the DXRX marketplace and avail of the opportunity to work with a world renowned External Quality Assessment provider DXRX is the world\u2019s first diagnostic network for precision medicine, enabling industry-wide collaboration to get every patient the treatment they deserve PARSIPPANY, New Jersey&#8211;(BUSINESS WIRE)&#8211;Diaceutics PLC, (AIM: DXRX), today announces a strategic partnership with Canadian Pathology Quality Assurance (CPQA) to advance the development of Neurotrophic Tropomyosin Receptor Kinase (NTRK) IHC proficiency &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-416164","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing Canadian Pathology Quality Assurance will utilize the DXRX platform\u2019s global network to support global implementation of their pan-TRK program Partnership will enable CPQA to produce best-in-class Neurotrophic Tropomyosin Receptor KinaseIHC proficiency testing Laboratories can sign up to the DXRX marketplace and avail of the opportunity to work with a world renowned External Quality Assessment provider DXRX is the world\u2019s first diagnostic network for precision medicine, enabling industry-wide collaboration to get every patient the treatment they deserve PARSIPPANY, New Jersey&#8211;(BUSINESS WIRE)&#8211;Diaceutics PLC, (AIM: DXRX), today announces a strategic partnership with Canadian Pathology Quality Assurance (CPQA) to advance the development of Neurotrophic Tropomyosin Receptor Kinase (NTRK) IHC proficiency &hellip; Continue reading &quot;Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-19T00:34:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing\",\"datePublished\":\"2021-01-19T00:34:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/\"},\"wordCount\":774,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210118005033\\\/en\\\/852608\\\/4\\\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/\",\"name\":\"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210118005033\\\/en\\\/852608\\\/4\\\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\",\"datePublished\":\"2021-01-19T00:34:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210118005033\\\/en\\\/852608\\\/4\\\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210118005033\\\/en\\\/852608\\\/4\\\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/","og_locale":"en_US","og_type":"article","og_title":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk","og_description":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing Canadian Pathology Quality Assurance will utilize the DXRX platform\u2019s global network to support global implementation of their pan-TRK program Partnership will enable CPQA to produce best-in-class Neurotrophic Tropomyosin Receptor KinaseIHC proficiency testing Laboratories can sign up to the DXRX marketplace and avail of the opportunity to work with a world renowned External Quality Assessment provider DXRX is the world\u2019s first diagnostic network for precision medicine, enabling industry-wide collaboration to get every patient the treatment they deserve PARSIPPANY, New Jersey&#8211;(BUSINESS WIRE)&#8211;Diaceutics PLC, (AIM: DXRX), today announces a strategic partnership with Canadian Pathology Quality Assurance (CPQA) to advance the development of Neurotrophic Tropomyosin Receptor Kinase (NTRK) IHC proficiency &hellip; Continue reading \"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-19T00:34:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing","datePublished":"2021-01-19T00:34:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/"},"wordCount":774,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/","name":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg","datePublished":"2021-01-19T00:34:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20210118005033\/en\/852608\/4\/Karina_Hjort%2C_Senior_Director%2C_Innovation_at_Diaceutics_2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Canadian Pathology Quality Assurance Leverages Diaceutics\u2019 DXRX Platform to Advance NTRK IHC Proficiency Testing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=416164"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416164\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=416164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=416164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=416164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}